News Focus
News Focus
Followers 7
Posts 354
Boards Moderated 0
Alias Born 11/13/2016

Re: RedShoulder post# 358612

Wednesday, 04/27/2022 3:44:40 PM

Wednesday, April 27, 2022 3:44:40 PM

Post# of 517224
Red & plexrec,

I watched this mornings presentation and will say that TGD is coming off as very comfortable and confident in making these presentations. The Stock Twits post sums it up quite well but I also feel TGD is doing a better job of explaining all the upstream
benefits of 2-73 and how much better it is than a drug that just targets amyloid/tau.

Early on in his presentation, he definitely covered the potential prophylactic market,
talking about how the animal studies showed 2-73 prevented AD. Once the MOA
is confirmed in the AD phase 2b/3 trial later this year, Wall Street might finally start
factoring in the enormous size of the prevention market in their calculations for
Anavex.

jmvho
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News